000917031 000__ 03525cam\a2200469Ii\4500
000917031 001__ 917031
000917031 005__ 20230306150553.0
000917031 006__ m\\\\\o\\d\\\\\\\\
000917031 007__ cr\cn\nnnunnun
000917031 008__ 191112s2019\\\\si\a\\\\o\\\\\001\0\eng\d
000917031 019__ $$a1127286844$$a1129164253
000917031 020__ $$a9789811394355$$q(electronic book)
000917031 020__ $$a9811394350$$q(electronic book)
000917031 020__ $$z9789811394348
000917031 020__ $$z9811394342
000917031 0247_ $$a10.1007/978-981-13-9435-5$$2doi
000917031 0247_ $$a10.1007/978-981-13-9
000917031 035__ $$aSP(OCoLC)on1127235495
000917031 035__ $$aSP(OCoLC)1127235495$$z(OCoLC)1127286844$$z(OCoLC)1129164253
000917031 040__ $$aGW5XE$$beng$$erda$$epn$$cGW5XE$$dYDX$$dEBLCP$$dLQU$$dOCLCF
000917031 049__ $$aISEA
000917031 050_4 $$aQK603
000917031 08204 $$a579.5$$223
000917031 24500 $$aRecent trends in human and animal mycology /$$cKaruna Singh, Neelabh Srivastava, editors.
000917031 264_1 $$aSingapore :$$bSpringer,$$c2019.
000917031 300__ $$a1 online resource (xvii, 280 pages) :$$billustrations.
000917031 336__ $$atext$$btxt$$2rdacontent
000917031 337__ $$acomputer$$bc$$2rdamedia
000917031 338__ $$aonline resource$$bcr$$2rdacarrier
000917031 500__ $$aIncludes index.
000917031 5050_ $$aPart I Human and Animal Mycoses -- Pythiosis -- Superficial Mycoses in Dogs and Cats -- Pathogenic Chrysosporium-related Fungi in Reptiles and Other Animals -- Aspergillosis in Humans and Animals -- Some Clinically Significant Genera of Dematiaceous Hyphomycetes: An Update -- Endemic Mycoses in Americas -- Part II Mycotoxins in Relation to Human and Animal Health -- Mycotoxins and Their Inhalatory Intake Risk -- Tenuazonic acid:A Potent Mycotoxin -- Part III Antifungal Therapeutic Candidates -- Phytochemicals: New Avenues in Anti-Candidal Activity -- Recent Advances in Coumarins as Antifungal Agents.
000917031 506__ $$aAccess limited to authorized users.
000917031 520__ $$aFungal pathogens pose an on-going and serious threat for poikilotherms and homeotherms, and can cause a broad spectrum of diseases ranging from innocuous to life-threatening. In addition, long-term exposure to some mycotoxigenic moulds can lead to mycotoxicoses in human and animals. Given the expanding population of immune compromised hosts, the list of fungal opportunists grows longer every year. Moreover, antifungal resistance, drug-related toxicity and our limited arsenal of antifungals have exacerbated the situation. To address these problems, strategies such as the identification of novel targets, use of the structure-activity relationship in rational drug design, development of new formulations, modification of existing antifungals to combat resistance, and bioavailability enhancement are called for. For the readers convenience, this book has been divided into three sections. The first six chapters of Section I provide a timely review of mycoses, from endemic to cosmopolitan and from generalized to specific, while both chapters of Section II focus on risks associated with mycotoxins. In closing, the two chapters of Section III describe potential antifungal leads and drug candidates based on phytochemicals and coumarin scaffold.
000917031 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed November 12, 2019).
000917031 650_0 $$aMycology.
000917031 7001_ $$aSingh, Karuna,$$eeditor.
000917031 7001_ $$aSrivastava, Neelabh,$$eeditor.
000917031 77608 $$iPrint version: $$z9811394342$$z9789811394348$$w(OCoLC)1103687691
000917031 852__ $$bebk
000917031 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-981-13-9435-5$$zOnline Access$$91397441.1
000917031 909CO $$ooai:library.usi.edu:917031$$pGLOBAL_SET
000917031 980__ $$aEBOOK
000917031 980__ $$aBIB
000917031 982__ $$aEbook
000917031 983__ $$aOnline
000917031 994__ $$a92$$bISE